This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
РУКОВОДСТВО ДЛЯ АКТИВИСТОВ ПО ИНСТРУМЕНТАМ ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА ЯНВАРЬ.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
International Journal of Infectious Diseases 32 (2015) 111–117
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Euro Surveillance 2014;19(47):pii=20970, p.31-37
PeerJ PrePrints , http://dx.doi.org/10.7287/peerj.preprints.579v1 2 Nov 2014
Submitted to The Lesotho National Federation of Disabled (LNFOD)